{"name":"Grünenthal","slug":"grunenthal","ticker":"Private","exchange":"Private","domain":"grunenthal.com","description":"Grünenthal GmbH is a German pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban.","hq":"Aachen, Germany","founded":0,"employees":"","ceo":"Gabriel Baertschi","sector":"Pain / Neuroscience","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private","metrics":{"revenue":1800000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Duexis patent cliff ($1.2B at risk)","drug":"Duexis","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Placebo Plaster","genericName":"Placebo Plaster","slug":"placebo-plaster","indication":"Other","status":"phase_3"},{"name":"Lopain","genericName":"Lopain","slug":"lopain","indication":"Other","status":"phase_1"},{"name":"Matching Placebo (twice daily)","genericName":"Matching Placebo (twice daily)","slug":"matching-placebo-twice-daily","indication":"Other","status":"phase_3"},{"name":"Progesterone vaginal ring","genericName":"Progesterone vaginal ring","slug":"progesterone-vaginal-ring","indication":"Other","status":"phase_3"},{"name":"Tapentadol Prolonged Release with Pregabalin","genericName":"Tapentadol Prolonged Release with Pregabalin","slug":"tapentadol-prolonged-release-with-pregabalin","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"cardiovascular","drugs":[{"name":"Tapentadol Prolonged Release","genericName":"Tapentadol Prolonged Release","slug":"tapentadol-prolonged-release","indication":"Moderate to severe chronic pain in adults requiring opioid therapy","status":"marketed"},{"name":"CG5503 IR","genericName":"CG5503 IR","slug":"cg5503-ir","indication":"Chronic pain conditions (Phase 3 development)","status":"phase_3"},{"name":"Oxycodone/Naloxone Prolonged Release","genericName":"Oxycodone/Naloxone Prolonged Release","slug":"oxycodone-naloxone-prolonged-release","indication":"Chronic moderate to severe pain requiring prolonged opioid therapy","status":"marketed"},{"name":"Tramadol 50","genericName":"Tramadol 50","slug":"tramadol-50","indication":"Moderate acute and chronic pain","status":"phase_3"},{"name":"Tramadol/Diclofenac 50/50","genericName":"Tramadol/Diclofenac 50/50","slug":"tramadol-diclofenac-50-50","indication":"Moderate to severe pain","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"infectious","drugs":[{"name":"Clarithromycin DST (125 mg)","genericName":"Clarithromycin DST (125 mg)","slug":"clarithromycin-dst-125-mg","indication":"Bacterial respiratory tract infections","status":"phase_3"},{"name":"Clarithromycin DST (187.5 mg)","genericName":"Clarithromycin DST (187.5 mg)","slug":"clarithromycin-dst-187-5-mg","indication":"Bacterial respiratory tract infections","status":"phase_3"},{"name":"Clarithromycin DST (250 mg)","genericName":"Clarithromycin DST (250 mg)","slug":"clarithromycin-dst-250-mg","indication":"Bacterial respiratory tract infections","status":"phase_3"},{"name":"Clarithromycin Syrup (125 mg)","genericName":"Clarithromycin Syrup (125 mg)","slug":"clarithromycin-syrup-125-mg","indication":"Bacterial respiratory tract infections (community-acquired pneumonia, acute bronchitis)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"Topical analgesic","genericName":"Topical analgesic","slug":"topical-analgesic","indication":"Localized musculoskeletal pain","status":"marketed"},{"name":"Diclofenac 50","genericName":"Diclofenac 50","slug":"diclofenac-50","indication":"Acute pain (postoperative, dental, musculoskeletal)","status":"phase_3"},{"name":"Tramadol/Diclofenac 25/25","genericName":"Tramadol/Diclofenac 25/25","slug":"tramadol-diclofenac-25-25","indication":"Moderate to severe pain","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"respiratory","drugs":[{"name":"GRT9906","genericName":"GRT9906","slug":"grt9906","indication":"Chronic cough","status":"phase_2"},{"name":"RTX-GRT7039","genericName":"RTX-GRT7039","slug":"rtx-grt7039","indication":"Chronic cough","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Morphine Sulphate Controlled Release","genericName":"Morphine Sulphate Controlled Release","slug":"morphine-sulphate-controlled-release","indication":"Moderate to severe chronic pain","status":"phase_3"}]}],"pipeline":[{"name":"Morphine Sulphate Controlled Release","genericName":"Morphine Sulphate Controlled Release","slug":"morphine-sulphate-controlled-release","phase":"phase_3","mechanism":"Morphine sulphate is an opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and pain relief.","indications":["Moderate to severe chronic pain","Cancer pain"],"catalyst":""},{"name":"Placebo Plaster","genericName":"Placebo Plaster","slug":"placebo-plaster","phase":"phase_3","mechanism":"Placebo Plaster is an inert transdermal patch formulation designed to serve as a control comparator in clinical trials.","indications":[],"catalyst":""},{"name":"Tapentadol Prolonged Release","genericName":"Tapentadol Prolonged Release","slug":"tapentadol-prolonged-release","phase":"marketed","mechanism":"Tapentadol is a mu-opioid receptor agonist and noradrenaline reuptake inhibitor that provides analgesia through dual mechanisms.","indications":["Moderate to severe chronic pain in adults requiring opioid therapy"],"catalyst":""},{"name":"Topical analgesic","genericName":"Topical analgesic","slug":"topical-analgesic","phase":"marketed","mechanism":"Topical analgesics work by delivering pain-relieving agents directly to the skin and underlying tissues to reduce localized pain sensation.","indications":["Localized musculoskeletal pain","Minor arthritis pain","Muscle aches and strains"],"catalyst":""},{"name":"CG5503 IR","genericName":"CG5503 IR","slug":"cg5503-ir","phase":"phase_3","mechanism":"CG5503 is a selective inhibitor of transient receptor potential vanilloid 1 (TRPV1) that reduces pain signaling by blocking capsaicin-sensitive nociceptors.","indications":["Chronic pain conditions (Phase 3 development)"],"catalyst":""},{"name":"Clarithromycin DST (125 mg)","genericName":"Clarithromycin DST (125 mg)","slug":"clarithromycin-dst-125-mg","phase":"phase_3","mechanism":"Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","indications":["Bacterial respiratory tract infections","Helicobacter pylori eradication (as part of combination therapy)","Atypical pneumonia (Mycoplasma, Chlamydia)"],"catalyst":""},{"name":"Clarithromycin DST (187.5 mg)","genericName":"Clarithromycin DST (187.5 mg)","slug":"clarithromycin-dst-187-5-mg","phase":"phase_3","mechanism":"Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","indications":["Bacterial respiratory tract infections","Helicobacter pylori eradication (as part of combination therapy)","Mycobacterial infections (MAC prophylaxis/treatment)"],"catalyst":""},{"name":"Clarithromycin DST (250 mg)","genericName":"Clarithromycin DST (250 mg)","slug":"clarithromycin-dst-250-mg","phase":"phase_3","mechanism":"Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","indications":["Bacterial respiratory tract infections","Helicobacter pylori eradication (as part of combination therapy)","Atypical mycobacterial infections"],"catalyst":""},{"name":"Clarithromycin Syrup (125 mg)","genericName":"Clarithromycin Syrup (125 mg)","slug":"clarithromycin-syrup-125-mg","phase":"phase_3","mechanism":"Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and bacterial growth.","indications":["Bacterial respiratory tract infections (community-acquired pneumonia, acute bronchitis)","Otitis media","Sinusitis","Skin and soft tissue infections","Helicobacter pylori eradication (as part of combination therapy)"],"catalyst":""},{"name":"Diclofenac 50","genericName":"Diclofenac 50","slug":"diclofenac-50","phase":"phase_3","mechanism":"Diclofenac inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.","indications":["Acute pain (postoperative, dental, musculoskeletal)","Chronic inflammatory conditions (rheumatoid arthritis, osteoarthritis)","Dysmenorrhea"],"catalyst":""},{"name":"GRT9906","genericName":"GRT9906","slug":"grt9906","phase":"phase_2","mechanism":"GRT9906 is a selective antagonist of the P2X3 receptor that reduces pain signal transmission in sensory neurons.","indications":["Chronic cough","Neuropathic pain"],"catalyst":""},{"name":"Lopain","genericName":"Lopain","slug":"lopain","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Matching Placebo (twice daily)","genericName":"Matching Placebo (twice daily)","slug":"matching-placebo-twice-daily","phase":"phase_3","mechanism":"Matching placebo has no active pharmacological mechanism; it is an inert control formulation used in clinical trials.","indications":[],"catalyst":""},{"name":"Oxycodone/Naloxone Prolonged Release","genericName":"Oxycodone/Naloxone Prolonged Release","slug":"oxycodone-naloxone-prolonged-release","phase":"marketed","mechanism":"Oxycodone acts as a mu-opioid receptor agonist to provide analgesia, while naloxone is included to reduce the potential for abuse by blocking opioid effects if the tablet is crushed and injected.","indications":["Chronic moderate to severe pain requiring prolonged opioid therapy"],"catalyst":""},{"name":"Progesterone vaginal ring","genericName":"Progesterone vaginal ring","slug":"progesterone-vaginal-ring","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"RTX-GRT7039","genericName":"RTX-GRT7039","slug":"rtx-grt7039","phase":"phase_3","mechanism":"RTX-GRT7039 is a selective antagonist of the P2X3 receptor that reduces pain signaling by blocking ATP-mediated nociceptive transmission.","indications":["Chronic cough","Neuropathic pain"],"catalyst":""},{"name":"Tapentadol Prolonged Release with Pregabalin","genericName":"Tapentadol Prolonged Release with Pregabalin","slug":"tapentadol-prolonged-release-with-pregabalin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tramadol 50","genericName":"Tramadol 50","slug":"tramadol-50","phase":"phase_3","mechanism":"Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.","indications":["Moderate acute and chronic pain"],"catalyst":""},{"name":"Tramadol/Diclofenac 25/25","genericName":"Tramadol/Diclofenac 25/25","slug":"tramadol-diclofenac-25-25","phase":"phase_3","mechanism":"Tramadol is a centrally acting opioid analgesic, while diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis.","indications":["Moderate to severe pain","Osteoarthritis"],"catalyst":""},{"name":"Tramadol/Diclofenac 50/50","genericName":"Tramadol/Diclofenac 50/50","slug":"tramadol-diclofenac-50-50","phase":"phase_3","mechanism":"Tramadol is a centrally acting opioid analgesic, while diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis.","indications":["Moderate to severe pain","Inflammatory pain"],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Grünenthal Reports 2023 Full-Year Results","summary":"Grünenthal reported a revenue increase of 10% in 2023, driven by strong sales of its pain management products.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"deal","headline":"Grünenthal Partners with Biogen to Develop New Multiple Sclerosis Treatment","summary":"Grünenthal and Biogen announced a collaboration to develop a new multiple sclerosis treatment, with Grünenthal contributing its expertise in pain management.","drugName":"","sentiment":"positive"},{"date":"2022-03-15","type":"regulatory","headline":"Grünenthal's Duexis Receives FDA Approval for New Indication","summary":"The FDA approved Duexis, Grünenthal's anti-inflammatory product, for a new indication in the treatment of osteoarthritis.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxObWp0cGNpOWRzcl9FQnZtWGY3VWhJUGtscllWWlppYTVVSlBuZ1Z5cVVEQlZscW5qV2RaMDhWVVVwaU90UXBaQVJabWxPVzl3U01oY3RkZHBzbnlXcVRtMVhlSTZldXRsTEVfN3gxcG5DTmlMRWcyZ2M1RXpRUHVTYjg4V2JrbU5jZWNFTURwQnJNZ0tNTWs5YUF3YXRQWkU5bl84bndqVlZKS2QtRlE5NGVoMHVvZ3V2MXI5UXJRNnZOcGtuTng2WWc5WFBHSmZUYnU3Q0lxeUdEYlVxaTJIQWhaT0o1YVJoTWtoTA?oc=5","date":"2026-02-05","type":"deal","source":"PR Newswire","summary":"Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal - PR Newswire","headline":"Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQWG5vdGU0V2RIaWIzYVFhVEhCMzNzd1B4MXJHNnlpUzVBOFBKZlFmY3d6Vm82NlRIbnlfZS1idFYtYk13RzY2bXhqaFhTN1VJWGRiTEp4VVBUc3lDRFMzczF5RVV6YVZQM3g2VnBOQnd6QTBQS3hOai1HZmZPb3BzRTdPX0RnOElMUmEyeGQyX1B0SElMTjRnRUJ6ZFJYTGJPdkppdlVRMWZGUkxjOFFWbVlRYWdzYTFjUmh1X0hIVy02UQ?oc=5","date":"2025-02-24","type":"deal","source":"PR Newswire","summary":"Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal - PR Newswire","headline":"Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9kNGQtVXhYMmpBRHZpbEh4TXk1RXdiWWowNmxHMEM3TW1mSFRfMHE1R0NfeHBHYTN0RDJqUnYxLWVDd0wtZmtmRm9LYVVheDZCRm14X1Job182bDZIWkVHT1ItLW05bldOZG5sY3J3THg0ZF9fMnYwN0huWnBNZw?oc=5","date":"2024-07-23","type":"deal","source":"Pharmaceutical Technology","summary":"Grünenthal acquires Valinor Pharma - Pharmaceutical Technology","headline":"Grünenthal acquires Valinor Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNcy00QnJ3bFFTVllKa0twZ1oxdENCQ3NOcENMbDEydzJDM1BJYUEyT2llektNUVlWWHVzelU5NGNIZkc3SU54ZkZwT2JZX2d4bWtpNFJoTUpaQW16Sk1mZS13X25FaV9Wd1pGYzhUNGs4dmlSaUZFcVg3NGI2bG9JWmt3MXViUEpFamhiSXJKWlVDQ2Ry?oc=5","date":"2019-05-29","type":"pipeline","source":"New York Post","summary":"'The Pain League' allegedly pushed opioids in Italy - New York Post","headline":"'The Pain League' allegedly pushed opioids in Italy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOVGNRdWFqYmhOVW54OEVWbHpnQUd6bDhXaFh1QUFySTkyWkNHYUQ2ZHE5VkpZWTRhckJqWjlOZmdmODJwdUk1S2lnY3RvVHZ6YnJUMTV3c0dVNjc1Nl9BS0h2Y1VvSlNMTkVrc3U4NTVqdzNDNGM4Q1JGajlDcFdLMDdmOEVVN1Z3SF9sVXZuMEpkakVPNmpXUm90NlU?oc=5","date":"2018-10-31","type":"deal","source":"Pharmaceutical Technology","summary":"AstraZeneca signs $922m licensing deal with Grünenthal - Pharmaceutical Technology","headline":"AstraZeneca signs $922m licensing deal with Grünenthal","sentiment":"neutral"}],"patents":[{"drugName":"Duexis","drugSlug":"ibuprofen/famotidine","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1200000000}],"drugCount":20,"phaseCounts":{"phase_3":14,"marketed":4,"phase_2":1,"phase_1":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Pfizer","Johnson & Johnson","Merck & Co."],"therapeuticFocus":["Pain Management","Neuroscience"],"financials":null,"yahoo":null}